Summary:
A clinical study for Crohn’s Disease to Evaluate the Safety and Efficacy of a new medication in Subjects with Moderate to Severely Active Crohn’s Disease. Duration of the study is 52 weeks with optional extension for eligible subjects.
Criteria:- be ages 18-85
- Diagnosed with Ulcerative Colitis by colonoscopy or sigmoidoscopy and biopsy
- Have medical records to confirm their diagnosis and treatment or be able to provide authorization to request those records
- Received prior treatment (corticosteroids, anti-inflammatories, advanced drug therapies)
Qualified Participants May Receive:
- Study medication for duration of the clinical trial at no charge
- Medical care by Board Certified Gastroenterologist for the duration of the trial at no charge
- All study related procedures (colonoscopy or sigmoidoscopy) at no charge
- Compensation for participation and expenses up to $3,600 and more based on completion of study visits